anticorps PHLDA2, anticorps ipl, anticorps phlda2, anticorps BRW1C, anticorps BWR1C, anticorps HLDA2, anticorps IPL, anticorps TSSC3, anticorps Ipl, anticorps Tssc3, anticorps zgc:110459, anticorps pleckstrin homology like domain family A member 2, anticorps Pleckstrin homology-like domain family A member 2, anticorps pleckstrin homology like domain, family A, member 2, anticorps pleckstrin homology-like domain, family A, member 2, anticorps pleckstrin homology-like domain, family A, member 2 L homeolog, anticorps PHLDA2, anticorps phla2, anticorps Phlda2, anticorps phlda2.L, anticorps phlda2
Sujet
This gene is located in a cluster of imprinted genes on chromosome 11p15.5, which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver.,PHLDA2,BRW1C,BWR1C,HLDA2,IPL,TSSC3,Epigenetics & Nuclear Signaling,Cancer,Tumor suppressors,Cell Biology & Developmental Biology,Apoptosis,Cell Cycle,Cell cycle inhibitors,PHLDA2